Gene Query: ANKRD18B

Dataset Description Geneva Score
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 24.45
Recovery and analysis of nascent RNA 22.72
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 22.72
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 17.36
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 15.0
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 14.8
Peptidomimetic blockade of MYB in acute myeloid leukemia 14.8
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 14.67
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 14.67
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 14.07
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 10.74
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 10.74
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 10.49
The pause-initiation limit restricts transcription activation in human cells 9.01
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 8.83
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 8.83
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 8.45
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 8.28
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.82
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 7.03
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 6.8
Global Mapping of Human RNA-RNA Interactions 6.31
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 6.22
Impact on erythroid progenitor type on erythroid differntiation 6.2
Depicting early human development and germ cell origin with porcine embryos 6.1
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.88
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.88
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.8
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 5.74
Transcriptomic analysis of the HOTAIR-regulated genes 5.56
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 5.43
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 5.16
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 4.91
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.62
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 4.32
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 4.03
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 4.0
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.89
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 3.75
PTHrP overexpression in MCF7 cells 3.73
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.64
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.61
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 3.4
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 3.4
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 3.35
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 3.35
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 2.98
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 2.98
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.93
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.93
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 2.89
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.86
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.86
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 2.83
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.81
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 2.78
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 2.75
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 2.75
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.72
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 2.7
Lysine benzoylation is a novel histone mark 2.69
Lysine benzoylation is a novel histone mark [RNA-seq] 2.69
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.62
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 2.61
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.57
NRDE2 negatively regulates nuclear exosome functions 2.57
Universal alternative splicing of noncoding exons 2.55
Effect of Influenza virus infection on lncRNA expression in A549 cells 2.42
U1 snRNP telescripting regulates size-function stratified human genome 2.3
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.29
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 2.28
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 2.27
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 2.27
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.24
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.24
Mitochondrial dsRNA triggers antiviral signalling in humans 2.23
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 2.21
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.19
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 2.16
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 2.12
Uridylation by TUT4 and TUT7 marks mRNA for degradation 2.1
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 2.1
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 2.1
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 2.09
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 2.09
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.07
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.07
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 2.06
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 2.04
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.03
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 2.03
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.02
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 2.01
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 2.01
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 2.01
Dtx3L and Androgen Signaling in Prostate Cancer 2.0
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 2.0
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 2.0
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 1.96
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 1.96
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.96
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.95
In vitro modeling of human germ cell development using pluripotent stem cells 1.95
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.94
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.92
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.91
Investigation about fibroblasts of different origins in culture 1.86
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 1.85
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 1.85
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 1.84
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.84
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.83
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 1.82
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 1.79
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 1.76
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 1.75
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.71
A prostate cancer chromatin interaction map 1.71
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 1.68
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 1.66
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 1.62
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.61
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 1.6
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 1.59
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 1.59
JAK dependent survival of ALK- ALCL 1.58
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 1.57
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 1.57
MCF-7 as a model for functional analysis of breast cancer risk variants 1.56
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 1.56
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 1.56
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 1.56
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 1.55
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 1.55
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.54
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 1.54
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.53
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 1.51
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 1.51
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.49
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.49
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 1.45
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.44
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.42
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 1.42
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 1.41
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.41
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.41
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 1.4
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 1.4
m6A-dependent regulation of messenger RNA stability 1.39
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 1.37
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 1.34
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 1.34
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.32
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.32
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 1.32
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.31
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 1.28
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 1.27
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.26
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.26
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 1.26
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 1.26
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 1.26
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.26
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.25
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 1.25
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 1.24
Human cell line and subcutaneous tumor 1.24
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.24
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 1.23
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 1.21
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.21
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.21
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 1.19
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 1.19
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 1.16
The conserved transcriptional landscapes in human spermatogenesis 1.16
Transcriptome analysis of Zika infected neural stem cells 1.13
Zika infected neural stem cells 1.13
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.13
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.11
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 1.1
Tracking of dCas9-methyltransferase footprints 1.1
RNA-seq analysis to identify the genes regulated by p53-SET interplay 1.1
RNA sequencing of human mammary epithelial cells 1.1
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.09
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.09
Capturing the Interactome of Newly Transcribed RNA 1.09
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.09
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 1.07
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 1.06
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.05
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.05
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.05
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.04
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 1.03
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 1.01
RNA seq comparison between scrambled and shGRP78 cells 1.0
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.0
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.0
CHCHD2 gene KO effect in iPSC drived motor neurons 1.0
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.0
Transcriptome analysis of H9 hESC derived cerebral organoids 0.99
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.98
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 0.98
High-throughput sequencing of PROMPT-enriched samples. 0.98
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 0.98
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 0.97
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.96
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 0.96
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 0.96
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.94
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 0.94
TGF-β promotes genomic instability after loss of RUNX3 0.93
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.92
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 0.91
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.9
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 0.89
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 0.89
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 0.89
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 0.89
Global transcriptome analysis of HAP1 cells 0.89
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 0.88
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.88
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.88
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.88
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 0.88
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 0.88
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 0.87
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 0.87
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.87
Reassessment of Exosome Composition 0.87
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.87
Integrin signaling regulates YAP/TAZ to control skin homeostasis 0.87
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 0.87
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.86
Effect of nuclear IL-33 on gene expression 0.86
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 0.85
CHCHD10 gene KO effect in iPSC drived motor neurons 0.85
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.84
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.84
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.84
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 0.84
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.84
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 0.83
Targeting MTHFD2 in Acute Myeloid Leukemia 0.83
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 0.81
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 0.81
RNA-seq analyisis of PUM2 knockout cells 0.8
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.8
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.8
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 0.79
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 0.79
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 0.79
circRNA-sequencing 0.79
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 0.78
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 0.78
Global analysis of alternative splicing regulated by RBM10 0.77
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 0.77
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 0.77
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 0.77
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 0.77
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 0.76
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 0.76
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 0.76
Cleavage Factor Im as a key regulator of 3’ UTR length 0.75
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 0.75
DRB/GRO-Seq -/+ UV 0.75
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 0.75
RNA-seq analysis of differentiating human erythroblasts 0.74
Gene expression analysis of the impact of TDP-43 knockout in human cells. 0.74
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.74
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 0.74
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 0.74
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 0.74
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 0.74
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 0.73
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 0.73
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.72
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.71
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.71
LIN28A Over-expression RNAseq 0.71
Transcriptional landscape changes during human embryonic stem cell derivation 0.71
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 0.71
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 0.71
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.71
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.71
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 0.7
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 0.7
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.7
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.7
RNA transcriptome analysis during HSV-1 infection 0.7
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 0.69
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.69
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.69
scRNASeq analysis of cycling cardiomyocytes 0.69
Gene expression changes associated with resistance to tagraxofusp (SL-401) 0.69
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 0.69
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 0.69
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 0.69
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.68
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.68
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 0.66
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.65
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.65
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.65
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 0.65
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 0.65
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 0.64
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 0.63
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 0.63
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 0.63
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 0.63
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.62
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.62
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 0.62
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 0.62
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 0.62
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.61
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.61
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 0.6
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 0.59
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.59
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 0.58
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.57
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 0.57
Transcription control by the ENL YEATS domain in acute leukemia 0.57
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 0.57
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.56
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.56
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 0.56
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 0.56
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.55
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 0.55
Transcriptome landscape of HeLa response upon triamcinolone acetonide 0.55
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.55
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.55
Neonatal and adult human testis defined at the single-cell level 0.55
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.54
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.54
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 0.54
RNA-sequencing of formalin fixed human primary melanoma tissue 0.54
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 0.53
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.53
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.53
TGF-β regulation of miRNA expression in pancreatic cancer 0.53
Genome-wide analysis of the Integrator complex (HTS) 0.53
Genome-wide analysis of the Integrator complex 0.53
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.53
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 0.53
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.52
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.51
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.51
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 0.49
RNA sequencing of human pancreatic cancer cell lines 0.48
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.48
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.48
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 0.47
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 0.47
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 0.47
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.47
MicroRNA-125a-5p overexpression in human macrophages 0.46
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.46
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.44
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 0.44
Analyses of T-ALL (COG study) 0.43
RNA sequencing of T-ALL (COG study) 0.43
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.43
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.43
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 0.43
Function and hormonal regulation of GATA3 in human first trimester placentation 0.42
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.42
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.41
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 0.41
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 0.41
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.41
Transcriptome of human white and brown adipose tissue biopsies 0.4
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.4
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.4
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 0.4
miR941 overexpression experiment 0.39
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.39
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.38
iPSC-Derived Cholangiocytes 0.37
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 0.37
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.37
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.37
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.37
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.36
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.36
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.35
The cohesin release factor WAPL restricts chromatin loop extension. 0.35
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.35
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.35
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 0.35
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 0.34
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.34
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.34
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.34
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 0.33
Global transcriptome analysis of WT versus HEB-/- hESCs 0.32
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.32
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 0.32
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.32
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.32
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.32
The landscape of alternative splicing in aggressive prostate cancers 0.31
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.3
Determination of tRNA aminoacylation levels by high throughput sequencing 0.3
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.29
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 0.29
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.28
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.26
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.26
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.25
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.25
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.25
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.24
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.24
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 0.23
Gene profiling of human adult and pediatric liver cancer cells 0.23
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.22
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.22
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.22
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.21
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.21
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 0.21
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.21
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.21
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.2
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.2
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.2
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 0.2
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.2
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 0.19
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.18
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.18
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.18
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 0.18
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.18
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.17
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 0.17
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.17
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.16
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.16
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.16
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.16
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.15
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.15
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.14
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.14
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.14
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.12
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.12
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.12
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.12
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.11
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 0.11
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.11
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 0.11
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 0.11
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.1
RNAseq analysis of ruxolitinib treated breast cancers 0.1
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 0.09
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.09
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.08
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.08
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 0.08
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.08
UV_24h_GRO-Seq 0.08
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.08
Specific molecular signatures underlie response to decitabine in CMML 0.08
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.07
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.07
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.07
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.06
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.06
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 0.05
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.05
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.05
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.04
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.04
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.04
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.04
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.04
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.03
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.03
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.03
ML29755 RNA-seq data 0.03
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.02
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.02
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.02
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.02
Human Tfh cell RNA bulk sequencing 0.01
Leucegene: AML sequencing (part 6) 0.0
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation